Brief: Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
June 1 (Reuters) - Lifecore Biomedical Inc LFCR.O :
* LIFECORE BIOMEDICAL REPORTS THIRD QUARTER FISCAL YEAR 2023
RESULTS
* LIFECORE BIOMEDICAL INC - COMPANY HAS REMOVED ITS
PREVIOUSLY
ANNOUNCED GOING CONCERN QUALIFICATION
* LIFECORE BIOMEDICAL INC - QTRLY TOTAL DILUTED NET LOSS PER
SHARE
$1.33
Source text for Eikon: ID:nGNX8Lxwd0
Further company coverage: LFCR.O
Recent news on Lifecore Biomedical
See all newsNASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:40 AM
Lifecore Biomedical, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Lifecore Biomedical Reports Financial Results
Lifecore Biomedical Inc expected to post a loss of 22 cents a share - Earnings Preview